Aethlon Medical (AEMD) Gains from Investment Securities (2016)
Aethlon Medical's (AEMD) quarterly Gains from Investment Securities came in at $345841.0 in Q2 2016.
Aethlon Medical (AEMD) Gains from Investment Securities (2016) Analysis & Trends
Aethlon Medical (AEMD) has 1 years of Gains from Investment Securities data on file, last reported at $345841.0 in Q2 2016.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $345841.0 in Q2 2016, while the trailing twelve-month figure through Mar 2017 was $345841.0 (changed N/A YoY) and the FY2017 annual result came in at $345841.0, changed N/A from the prior year.
- Gains from Investment Securities steadied at $345841.0 in Q2 2016.
- In the past five years, Gains from Investment Securities ranged from a high of $345841.0 in Q2 2016 to a low of $345841.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Aethlon Medical | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 345,841.00 |
| Jun 30, 2016 | 345,841.00 |